Tzield update | Breakthrough T1D
UPDATE: January 5, 2026 – Canada’s Drug Agency has just announced a decision not to reimburse Tzield (teplizumab) In Canada, reimbursement of therapeutics is based on recommendations from Canada’s...
breakthrought1d.ca